14.72
Precedente Chiudi:
$14.12
Aprire:
$14.19
Volume 24 ore:
756.92K
Relative Volume:
0.87
Capitalizzazione di mercato:
$1.28B
Reddito:
$2.01B
Utile/perdita netta:
$-253.84M
Rapporto P/E:
-4.8105
EPS:
-3.06
Flusso di cassa netto:
$115.19M
1 W Prestazione:
+13.93%
1M Prestazione:
+12.20%
6M Prestazione:
+3.30%
1 anno Prestazione:
+45.31%
Pediatrix Medical Group Inc Stock (MD) Company Profile
Nome
Pediatrix Medical Group Inc
Settore
Industria
Telefono
(954) 384-0175
Indirizzo
1301 CONCORD TERRACE, SUNRISE, FL
Confronta MD con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MD
Pediatrix Medical Group Inc
|
14.72 | 1.23B | 2.01B | -253.84M | 115.19M | -3.06 |
![]()
HCA
Hca Healthcare Inc
|
390.31 | 89.60B | 72.70B | 5.97B | 7.29B | 23.79 |
![]()
THC
Tenet Healthcare Corp
|
170.48 | 14.72B | 20.52B | 1.46B | 1.41B | 15.12 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
24.20 | 14.15B | 20.92B | 666.06M | 1.85B | 1.1422 |
![]()
EHC
Encompass Health Corp
|
118.63 | 11.83B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
175.21 | 10.92B | 16.08B | 1.20B | 1.06B | 17.82 |
Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-16 | Iniziato | Macquarie | Outperform |
2024-09-26 | Aggiornamento | Jefferies | Hold → Buy |
2024-06-07 | Aggiornamento | Deutsche Bank | Sell → Hold |
2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
2021-06-23 | Ripresa | Stifel | Hold |
2020-10-19 | Downgrade | Deutsche Bank | Hold → Sell |
2020-01-03 | Downgrade | Citigroup | Buy → Neutral |
2019-12-12 | Aggiornamento | Stifel | Hold → Buy |
2019-09-06 | Downgrade | BofA/Merrill | Neutral → Underperform |
2019-01-15 | Aggiornamento | Citigroup | Neutral → Buy |
2019-01-03 | Iniziato | Deutsche Bank | Hold |
2018-11-16 | Iniziato | UBS | Sell |
2018-09-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
2018-09-18 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
2018-08-03 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2018-07-12 | Iniziato | Leerink Partners | Mkt Perform |
2018-03-27 | Iniziato | Credit Suisse | Neutral |
2018-02-12 | Reiterato | Mizuho | Neutral |
2017-12-13 | Iniziato | Piper Jaffray | Overweight |
2017-09-18 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
2017-05-30 | Reiterato | Mizuho | Neutral |
2017-05-25 | Reiterato | Stifel | Hold |
2017-05-04 | Downgrade | BofA/Merrill | Buy → Underperform |
2017-03-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
2017-03-10 | Downgrade | JP Morgan | Overweight → Neutral |
Mostra tutto
Pediatrix Medical Group Inc Borsa (MD) Ultime notizie
Thermo Fisher, ICU Medical, CONMED, Pediatrix Medical Group, and IQVIA Stocks Trade Up, What You Need To Know - TradingView
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock - Yahoo Finance
Pediatrix Medical Group's Q2 Earnings Surge: A Blueprint for Strategic Resilience in a Shifting Healthcare Landscape - AInvest
Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes - Zacks Investment Research
Pediatrix Medical Group, Inc. Just Beat EPS By 24%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Pediatrix Medical Group Exceeds Q2 Forecasts, Raises Full-Year Adjusted EBITDA Outlook - AInvest
Jefferies lowers Pediatrix Medical Group stock price target to $19 on eAPTC concerns - Investing.com Canada
Pediatrix Medical Group Breaks Above 200-Day Moving AverageBullish for MD - Nasdaq
Pediatrix Medical Group, Inc. (NYSE:MD) Q2 2025 Earnings Call Transcript - Insider Monkey
Deutsche Bank Adjusts Pediatrix Medical Group Price Target to $13 From $15, Maintains Hold Rating - MarketScreener
Pediatrix raises 2025 adjusted EBITDA guidance to $245M–$255M as NICU days climb 6% and cash flow strengthens - MSN
Pediatrix Medical Group: Q2 Earnings Snapshot - New Haven Register
Pediatrix Medical Group Inc (MD) (Q2 2025) Earnings Call Highlights: Strong EBITDA and Cash ... By GuruFocus - Investing.com Canada
Pediatrix Medical Group Inc (MD) (Q2 2025) Earnings Call Highlig - GuruFocus
Pediatrix (MD) Q2 EPS Jumps 56% - AOL.com
Decoding Pediatrix Medical Group Inc (MD): A Strategic SWOT Insi - GuruFocus
Pediatrix (MD) Q2 EPS Jumps 56% - The Motley Fool
Earnings call transcript: Pediatrix Medical Q2 2025 beats EPS forecast - Investing.com India
Earnings call transcript: Pediatrix Medical Q2 2025 beats EPS forecast By Investing.com - Investing.com Australia
Pediatrix Medical Group (MD) Appoints Kurt D. Newman to Board - Insider Monkey
Is Pediatrix Medical Group (MD) Poised for a Recovery in Women's Health and Neonatal Care? - AInvest
Pediatrix Medical Group's Q2 2025: Key Contradictions in Admin Fees, Growth Expectations, and Buyback Strategies - AInvest
Pediatrix Medical Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Order Book Volume Tilts Bullish on Pediatrix Medical Group Inc.Accurate Buy Point for Momentum Stocks Detected - beatles.ru
Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top Estimates - sharewise.com
Pediatrix Medical Group’s (NYSE:MD) Q2 Sales Beat Estimates - Yahoo Finance
Pediatrix Medical Group Inc Surpasses Q2 2025 Estimates with EPS of $0.46 and Revenue of $469 Million - GuruFocus
Pediatrix Medical Group tops Q2 expectations, raises 2025 outlook By Investing.com - Investing.com Australia
Pediatrix Medical reports Q2 adjusted EPS 53c, consensus 42c - TipRanks
Pediatrix Medical (MD) Projects FY25 Adjusted EBITDA Between $245M and $255M - GuruFocus
Pediatrix Medical Group Raises Outlook After Strong Quarter - Finimize
Pediatrix Medical (MD) Exceeds Revenue Expectations and Raises 2025 EBITDA Outlook - GuruFocus
Pediatrix Medical Group tops Q2 expectations, raises 2025 outlook - Investing.com
Pediatrix Medical (MD) Exceeds Revenue Expectations and Raises 2 - GuruFocus
Pediatrix Medical (MD) Projects FY25 Adjusted EBITDA Between $24 - GuruFocus
Pediatrix Medical Group Reports Second Quarter Results | MD Stock News - GuruFocus
Physician services firm Pediatrix beats Q2 revenue estimates, raises 2025 EBITDA outlook - MarketScreener
Earnings Flash (MD) Pediatrix Medical Group, Inc. Reports Q2 Revenue $468.8M, vs. FactSet Est of $464.4M - MarketScreener
Pediatrix Medical Group Reports Second Quarter Results - Enidnews.com
Earnings To Watch: Pediatrix Medical Group (MD) Reports Q2 Results Tomorrow - Yahoo Finance
Is Pediatrix Medical Group Inc. a good long term investmentMarket-crushing profits - Jammu Links News
What institutional investors are buying Pediatrix Medical Group Inc. stockDiscover breakthrough stocks with expert help - Jammu Links News
What catalysts could drive Pediatrix Medical Group Inc. stock higher in 2025Capitalize on fast-growing stocks today - Jammu Links News
How many analysts rate Pediatrix Medical Group Inc. as a “Buy”Consistently outstanding ROI - Jammu Links News
What is Pediatrix Medical Group Inc. company’s growth strategyRealize consistent double-digit growth - Jammu Links News
Why is Pediatrix Medical Group Inc. stock attracting strong analyst attentionMaximize returns with strategic portfolio planning - Jammu Links News
How does Pediatrix Medical Group Inc. compare to its industry peersRapid-fire capital growth - Jammu Links News
What is the dividend policy of Pediatrix Medical Group Inc. stockUnlock exclusive investment alerts - Jammu Links News
Pediatrix Medical Group Inc. Stock Analysis and ForecastMaximize your gains with expert trading tips - Jammu Links News
Is Pediatrix Medical Group Inc. a growth stock or a value stockFree Risk Assessment Services - Jammu Links News
What makes Pediatrix Medical Group Inc. stock price move sharplyUnlock powerful investment tools for free - Jammu Links News
Pediatrix Medical Group Inc Azioni (MD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):